All Sections
Scotland's National Newspaper
BREAKING
Lego scraps plans to make bricks out of recycled plastic bottles
NCIS & The Man from U.N.C.L.E. actor David McCallum dies aged 90
Rishi Sunak 'alarmed' by costs of HS2 project amid Cabinet split
Russel Brand: Met receive number of sex offence allegations
'Cowardly ambush': Boy aged 15 stabbed in the back with kitchen knife
Lucy Letby to face retrial on allegation she tried to murder baby girl

Glasgow spin-out raises £4.5m for diabetes treatment

A university spin-out company that specialises in potential treatments for type 2 diabetes patients has secured a £4.5 million investment.
By PERRY GOURLEY
Published 5th Nov 2015, 08:19 BST
An estimated 380 million people worldwide have type 2 diabetesAn estimated 380 million people worldwide have type 2 diabetes
An estimated 380 million people worldwide have type 2 diabetes

Glasgow-based Caldan Therapeutics has attracted the funding deal led by Epidarex Capital, a leading international early-stage life science venture capital fund that has partners including drugs giant Eli Lilly.

Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the investment in the company, which is a spin-out from the universities of Glasgow and Southern Denmark.

Hide Ad
Hide Ad

Caldan focuses on creating drugs that could stimulate a range of anti-diabetic effects in multiple tissues and organs.

It is estimated that there are 380 million people with type 2 diabetes worldwide, with the figure estimated to rise to 592 million by 2035.

Graeme Milligan, professor of molecular pharmacology at the University of Glasgow, said: “We’re very pleased that Caldan is receiving the backing of Epidarex Capital and their partners.

“The underpinning basic science studies that have pointed the way to assess this new type of treatment for type 2 diabetes has been a true multidisciplinary collaboration between researchers here in Glasgow and our partners in Denmark. Our combined knowledge has led us to develop approaches we would never have created individually.”